IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of IMV Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. IMV Inc market cap is $7.61M.
What is the 52-week high for IMV Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. IMV Inc 52 week high is $0.0195 as of October 10, 2025.
What is the 52-week low for IMV Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. IMV Inc 52 week low is $0.00 as of October 10, 2025.
What is IMV Inc stock price today?
IMV Inc stock price today is $0.0195.
What is the 50-day moving average of IMV Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. IMV Inc 50-day moving average is $0.0027.